Histologic findings of femoral heads from patients with Gaucher disease treated with enzyme replacement

American Journal of Clinical Pathology

Volumn 140, Issue 1, 2013, Pages 91-96

  Lebel, Ehud ^a   Elstein, Deborah ^b   Peleg, Ariel ^b   Reinus, Constantine ^b   Zimran, Ari ^b   Amir, Gail ^c  

^a Department of Orthopedic Surgery ^*  (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Bone histology; Enzyme replacement therapy; Gaucher cells; Gaucher disease; Osteonecrosis

Indexed keywords

ENZYME;

ARTICLE; BONE DISEASE; BONE REGENERATION; CELL INFILTRATION; CLINICAL FEATURE; DISEASE SEVERITY; ENZYME REPLACEMENT; FEMALE; FEMUR HEAD NECROSIS; GAUCHER DISEASE; GENOTYPE; HIP ARTHROPLASTY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; RISK FACTOR; SPLENECTOMY;

BONE HISTOLOGY; ENZYME REPLACEMENT THERAPY; GAUCHER CELLS; GAUCHER DISEASE; OSTEONECROSIS;

ADOLESCENT; ADULT; AGED; BONE REGENERATION; ENZYME REPLACEMENT THERAPY; FEMALE; FEMUR HEAD; GAUCHER DISEASE; GENOTYPE; GLUCOSYLCERAMIDASE; HUMANS; MALE; MIDDLE AGED; MUTATION; OSTEOARTHRITIS; OSTEONECROSIS; RISK; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84879423884     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPFVSAEGO67NGT     Document Type: Article

References (10)

1. Zimran A, Elstein D. Lipid storage diseases. In: Kaushansky K, Lichtman MA, Beutler E, et al, eds. Williams' Hematology. 8th ed. New York, NY: McGraw-Hill; 2010:1065-1071.
2. Mistry PK, Weinreb NJ, Kaplan P, et al. Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults. Blood Cells Mol Dis. 2011;46:66-72.
3. Elstein D, Itzchaki M, Mankin HJ. Skeletal involvement in Gaucher's disease. Baillieres Clin Haematol. 1997;10:793-816.
4. Mikosch P, Hughes D. An overview on bone manifestations in Gaucher disease. Wien Med Wochenschr. 2012;160:609-624.
5. Barton NW, Brady RO, Dambrosia JM, et al. Replacement therapy for inherited enzyme deficiency-macrophagetargeted glucocerebrosidase for Gaucher's disease. N Engl J Med. 1991;324:1464-1470.
6. Lebel E, Phillips M, Elstein D, et al. Poor results of drilling in early stages of juxta-articular osteonecrosis in 12 joints affected by Gaucher disease. Acta Orthop. 2009;80:201-204.
7. Lebel E, Elstein D, Zimran A, et al. Cementless total hip arthroplasties in Gaucher disease: long-term follow-up. Am J Orthop. 2009;38:130-132.
8. Bubbar V, Heras FL, Amato D, et al. Total hip replacement in Gaucher's disease: effects of enzyme replacement therapy. J Bone Joint Surg Br. 2009;91:1623-1627.
9. Zimran A, Sorge J, Gross E, et al. Prediction of severity of Gaucher's disease by identification of mutations at DNA level. Lancet. 1989;12:349-352.
10. Khan A, Hangartner T, Weinreb NJ, et al. Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease-a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry. J Bone Miner Res. 2012;27:1839-1848.